Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-ketamine and immune microenvironment in perioperative cervical cancer surgery
ChiCTR2400084159Phase 4Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Cervical Cancer (CC) (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoints: PD1-PDL1 alteration, CTCs alteration and 1 more. Started May 2024; status: recruiting.
02
Drugs
esketamine
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on ChiCTR2400084159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400084159.